Participations à des congrès et colloques internationaux (42)
4.
Bouchart, C., Trepant, A.-L., Hein, M., Van Gestel, D., Salmon, I., & Demetter, P. (2018). Evolution of OLIG2 expression during radio(chemo)therapy has a prognostic value in glioblastoma. [poster]. Radiotherapy and oncology, 127 , 1280-1281.5.
Verset, L., Debroux, S., Eisendrath, P., Toussaint, E., Marechal, R., Van Laethem, J.-L., Charara, F., Closset, J., Loi, P., Pezzullo, M., Delhaye, M., Arvanitakis, M., & Demetter, P. (2018). A rare variant of conventional pancreatic ductal adenocarcinoma. Paper session presented at Belgian week of gastroenterology (XXXth Edition: 21/02/2018: Antwerp).6.
Bienfait, L., Doukoure, B., D'Haene, N., Salmon, I., Demetter, P., & Verset, L. (2017). Location and sex predominance of mismatch repair deficient colorectal cancer in Ivory Coast differ from its European counterpart. United European Gastroenterology Journal 2017; 5 (Supplement 1) Abstract session presented at UEG Week 2017(Barcelona, Spain)7.
Bienfait, L., Buggenhout, A., Quackels, T., Verset, L., & Demetter, P. (2017). IgG4-related inflammatory pseudotumour after radical prostatectomy: a case report. Poster présenté à la conférence Belgian Week Pathology 2017 (19-21/10/2017: Gent, Belgium).8.
Bienfait, L., Doukoure, B., D'Haene, N., Salmon, I., Decaestecker, C., Demetter, P., & Verset, L. (2017). Mismatch repair deficient colorectal cancer: comparison of an Ivory Coast with a Belgian cohort. Poster présenté à la conférence Belgian Week Pathology 2017 (19-21/10/2017: Gent, Belgium.).9.
Trepant, A.-L., D'Haene, N., Allard, J., Van Eycke, Y.-R., Decaestecker, C., Salmon, I., & Demetter, P. (2016). Vascular Insulin-Like Growth Factor Receptor Type 2 (IGF2R) Expression is Upregulated in Malignant Tumours. The Journal of Pathology, Volume 240, Issue Supplement S1 (p. 22) Abstract session presented at Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(9th: 28 June – 1 July 2016: Nottingham).11.
Trepant, A.-L., Maris, C., D'Haene, N., Sauvage, S., Rorive, S., Decaestecker, C., Salmon, I., & Demetter, P. (2015). Role of IGFIIR/Man-6-P in Glioblastoma angiogenesis. Dublin Pathology 2015: Plenary Oral and Oral Abstracts (p. 7) Abstract session presented at Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(8 th: 23 – 25 June 2015: Dublin).12.
Verset, L., Tommelein, J., Moles Lopez, X., Decaestecker, C., Boterberg, T., De Vlieghere, E., Salmon, I., Mareel, M., Bracke, M., De Wever, O., & Demetter, P. (2015). Impact of neoadjuvant therapy on cancer-associated fibroblast in rectal cancer. Dublin Pathology 2015: Plenary Oral and Oral Abstracts (p. 12) Abstract session presented at Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(8th: 23 – 25 June 2015: Dublin).13.
De Smedt, L., Lemahieu, J., Palmans, S., Govaere, O., Tousseyn, T., Van Cutsem, E. P., Prenen, H., Tejpar, S., Decaestecker, C., Moles Lopez, X., Demetter, P., Salmon, I., & Sagaert, X. (2015). Microsatellite instability versus microsatellite stability in colon carcinoma: documentation of tumour heterogeneity and inflammation. 2015 Belgian Week Abstracts (p. 117) Abstract session presented at Belgian Week of Gastroenterology(XXVIIth : February 2015: Brussels).14.
Trepant, A.-L., Bouchart, C., Rorive, S., Sauvage, S., Decaestecker, C., Demetter, P., & Salmon, I. (2014). Identification of OLIG2 as most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. International Journal Of Molecular Medicine. Vol. 34 (pp. S43-S43) Abstract session presented at 19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medecine(October 9-11, 2014: Athens).15.
Lepida, A., Puleo, F., Degré, D., Verset, L., Demetter, P., Gustot, T., Schreiber, J., Adler, M., Trepo, E., & Moreno, C. (2014). Controlled attenutation parameter for the evaluation of hepatic steatosis in ALD and NAFLD. Abstract session presented at Belgian Week of gastroenterology(XXVIth Edition: 12/02/2014: Dolce la Hulpe)